Protalix BioTherapeutics, Inc. Website Screenshot

Protalix BioTherapeutics, Inc. Company Intro

Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in Israel and internationally. The company offers Elelyso, a plant cell expressed recombinant glucocerebrosidase enzyme for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in phase III clinical trials for the treatment of Fabry diseases; OPRX-106, an orally-delivered protein product candidate for the treatment of inflammatory bowel disease, as well as completed Phase IIa clinical trial for ulcerative colitis patients; PRX-110, a proprietary plant cell recombinant form of human deoxyribonuclease I that has completed phase IIa clinical trials for the treatment of cystic fibrosis; and PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. Protalix BioTherapeutics, Inc. was founded in 1993 and is headquartered in Karmiel, Israel.



Protalix BioTherapeutics, Inc. Headquaters

2 Snunit Street

Protalix BioTherapeutics, Inc. Share price

14 Sep 2022 10:02 GMT


0.0 (0.0 %)

Protalix BioTherapeutics, Inc. Market cap

$48.062 M



Protalix BioTherapeutics, Inc. # 86


Latest Protalix BioTherapeutics, Inc. News

News 01 Dec 2022

Protalix And Chiesi Resubmit FDA Application For Rare ...

Protalix BioTherapeutics, Inc. (NYSE AMERICAN: PLX), an Israeli biopharmaceutical company, and Chiesi Global Rare Diseases, a business unit of the Chiesi...

News 30 Nov 2022

2022-11-30 | NYSEAM:PLX | Press Release | Protalix ...

Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment. PLX | 6 hours ago. (NewsDirect). Protalix BioTherapeutics, Inc. (NYSE...

News 29 Nov 2022

Fabry Disease Pipeline as Novel and Extensive 18+ ...

... Protalix, Sanofi Genzyme, Sangamo Therapeutics, 4D Molecular Therapeutics, Resverlogix Corp, AVROBIO, Freeline Therapeutics, Ozmosis Research Inc.,...

WMC Market Score

WMC Market to Revenue Score

Protalix BioTherapeutics, Inc. Market Financials

Revenue, Expenses, Profit

Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Protalix BioTherapeutics, Inc. USD $52,572 $46,048 $-13,665 $481M 86
Regeneron Pharmaceuticals, Inc. USD $9,197,600 $3,997,800 $4,003,800 $754,300B 1
Vertex Pharmaceuticals Incorporated USD $6,414,881 $2,617,257 $2,762,032 $713,610B 2
Alexion Pharmaceuticals, Inc. USD $6,261,601 $2,747,200 $681,800 $ 3
Incyte Corporation USD $2,702,913 $2,048,306 $478,480 $150,520B 4

Market Analytics

Company Search vs Top 4 Industry Competitors

Total Protalix BioTherapeutics, Inc. Social Followers vs Top 4 Industry Competitors

Protalix BioTherapeutics, Inc. Post vs Top 4 Industry Competitors

Protalix BioTherapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors

Protalix BioTherapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors

Protalix BioTherapeutics, Inc. WMC Market Score Calculations

Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Protalix BioTherapeutics, Inc. 0.57 0 0 0 0 0 0.01
Regeneron Pharmaceuticals, Inc. 100 25.50 16.15 22 0 0 28.52
Vertex Pharmaceuticals Incorporated 69.75 35.68 8.95 33 0 0 34.78
Alexion Pharmaceuticals, Inc. 68.08 100 100 22 0 0 100
Incyte Corporation 29.39 5.03 0.04 100 0 0 47.37

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb